Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Discover online savings accounts with top yield and solid terms. We compare rates, fees, and access so you pick the right option.
19,862 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
This year, a familiar name in disruptive investing is turning heads as one of its picks climbs about 30%. Learn what ...
The memory market is famous for wild swings. This guide breaks down what Micron does, where demand may come from, and...
Gaia’s Q1 2026 results reveal how the company is monetizing its growing audience and investing for long-term growth. ...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
As July 16 approaches, investors are weighing TSMC's Q2 results and what they mean for the stock. This article breaks...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
Energy Select Sector SPDR Fund (XLE) has staged a rebound as crude hits higher levels. Two key signals could set the ...
When a billionaire like David Tepper reportedly sold stakes in Nvidia and Amazon, it raises questions for regular inv...
The term stagflation can spark fear, but panicking won’t help. This guide breaks down what stagflation starting rear ...
A famous bear and a renowned economist throw down over where stocks go next. One foresees a milestone like 8,250 on t...